Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply. Hamilton MP, Miklos DB, Alizadeh AA. N Engl J Med 2024;391:870-871.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hamilton MP, Miklos DB, Alizadeh AA. Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply. N Engl J Med 2024;391:870-871.
PMID: 39231355